Market closedNon-fractional
CryoPort/CYRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About CryoPort
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Ticker
CYRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Life Sciences Tools and Services
Headquarters
Brentwood, United States
Employees
1,100
Website
www.cryoportinc.com
CryoPort Metrics
BasicAdvanced
$319M
Market cap
-
P/E ratio
-$2.47
EPS
1.60
Beta
-
Dividend rate
Price and volume
Market cap
$319M
Beta
1.6
Financial strength
Current ratio
10.733
Quick ratio
10
Long term debt to equity
86.654
Total debt to equity
87.875
Interest coverage (TTM)
-13.11%
Management effectiveness
Return on assets (TTM)
-4.39%
Return on equity (TTM)
-21.87%
Valuation
Price to revenue (TTM)
1.408
Price to book
0.68
Price to tangible book (TTM)
1.83
Price to free cash flow (TTM)
-6.851
Growth
Revenue change (TTM)
-9.19%
Earnings per share change (TTM)
219.23%
3-year revenue growth
22.57%
3-year earnings per share growth
8.96%
What the Analysts think about CryoPort
Analyst Ratings
Majority rating from 10 analysts.
CryoPort Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$55M
-4.72%
Net income
-$19M
-69.82%
Profit margin
-34.49%
-68.33%
CryoPort Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.42
-$0.31
-$1.31
-$0.43
-
Expected
-$0.24
-$0.31
-$0.29
-$0.35
-$0.39
Surprise
77.63%
1.64%
347.56%
23.56%
-
CryoPort News
AllArticlesVideos
As The Schall Law Firm Begins Investigating Claims Against Cryoport Inc, It Encourages Its Shareholders To Contact
Accesswire·11 hours ago
As The Schall Law Firm Starts Probing Allegations Against Cryoport Inc, Its Shareholders Are Urged To Get In Touch
Accesswire·3 days ago
Cryoport Inc Shareholders Are Encouraged To Connect As The Schall Law Firm Begins An Examination Of Allegations Against It
Accesswire·3 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for CryoPort stock?
CryoPort (CYRX) has a market cap of $319M as of July 06, 2024.
What is the P/E ratio for CryoPort stock?
The price to earnings (P/E) ratio for CryoPort (CYRX) stock is 0 as of July 06, 2024.
Does CryoPort stock pay dividends?
No, CryoPort (CYRX) stock does not pay dividends to its shareholders as of July 06, 2024.
When is the next CryoPort dividend payment date?
CryoPort (CYRX) stock does not pay dividends to its shareholders.
What is the beta indicator for CryoPort?
CryoPort (CYRX) has a beta rating of 1.6. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell CryoPort stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.